Related Experiment Video
Updated: May 3, 2026

In Vivo Modeling of the Morbid Human Genome using Danio rerio
Published on: August 24, 2013
Predicting Disease Onset from Mutation Status Using Proband and Relative Data with Applications to Huntington's
Tianle Chen1, Yuanjia Wang, Yanyuan Ma
1Department of Biostatistics, Mailman School of Public Health, Columbia University, 722 West 168th Street, New York, NY 10032, USA.
This study uses the expectation-maximization algorithm to estimate Huntington's disease (HD) onset risk by incorporating family member data. Including family data slightly lowers the estimated cumulative risk of HD symptom onset.
Area of Science:
- Genetics
- Neuroscience
- Biostatistics
Background:
- Huntington's disease (HD) is a progressive neurodegenerative disorder.
- CAG repeat expansion in the IT15 gene causes HD.
- Age-at-onset (AAO) correlates inversely with CAG repeat length.
Purpose of the Study:
- To accurately estimate the age-at-onset (AAO) distribution for Huntington's disease (HD).
- To incorporate missing genetic data from family members in the Cooperative Huntington's Observational Research Trial (COHORT) study.
- To improve genetic counseling and clinical trial design for HD.
Main Methods:
- Utilized the expectation-maximization (EM) algorithm to handle missing huntingtin gene information.
- Assumed family members with a huntingtin gene mutation share the same CAG length as the proband.
- Conducted simulation studies to evaluate the EM algorithm's performance.
- Applied the method to analyze combined proband and family data from the COHORT study.
Main Results:
- The expectation-maximization (EM) algorithm effectively handled missing genetic data in family members.
- Analysis of combined proband and family data yielded a slightly lower estimated cumulative risk of HD symptom onset compared to proband data alone.
- The study demonstrated the utility of integrating family genetic information for more refined HD risk assessment.
Conclusions:
- The expectation-maximization (EM) algorithm provides a robust method for imputing missing genetic data in familial studies.
- Incorporating data from first-degree relatives can refine Huntington's disease (HD) onset risk predictions.
- This approach enhances the accuracy of genetic counseling and clinical trial stratification for HD.
More Related Videos
09:34Targeted Next-generation Sequencing and Bioinformatics Pipeline to Evaluate Genetic Determinants of Constitutional Disease
Published on: April 4, 2018
07:15Determining the Likelihood of Variant Pathogenicity Using Amino Acid-level Signal-to-Noise Analysis of Genetic Variation
Published on: January 16, 2019
Related Concept Videos
Genetic Lingo
Pedigree Analysis
Probability Laws
Genome-wide Association Studies-GWAS
GWAS does not require the identification of the target gene involved in...
Pharmacogenomics: Identification of New Drug Targets
Huntington Disease l: Introduction